Xiaoran Long
Overview
Explore the profile of Xiaoran Long including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Long X, Lu H, Cai M, Zang J, Zhang Z, Wu J, et al.
Br J Cancer
. 2023 Mar;
128(11):2054-2062.
PMID: 36997661
Background: Ovarian clear cell carcinoma (OCCC) is a challenging disease due to its intrinsic chemoresistance. Immunotherapy is an emerging treatment option but currently impeded by insufficient understanding of OCCC immunophenotypes...
2.
Liu X, Lu H, Zhou Y, Long X, Li Q, Zhuang G, et al.
Cancer Med
. 2023 Mar;
12(10):11385-11395.
PMID: 36971044
Purpose: Ovarian clear cell carcinoma (OCCC) is a distinct and highly malignant subtype of ovarian cancer with high individual heterogeneity in survival that requires specific prognostic predictive tools. Thus, this...
3.
Dong Q, Long X, Cheng J, Wang W, Tian Q, Di W
Ann Transl Med
. 2022 Jan;
9(24):1770.
PMID: 35071464
Background: Long non-coding RNAs (lncRNAs) play critical roles in the occurrence and progression of various tumors, including ovarian cancer (OC). The lncRNA growth arrest-specific transcript 5 (GAS5) has been shown...
4.
Song K, Dai L, Long X, Wang W, Di W
Sci Rep
. 2020 Aug;
10(1):13834.
PMID: 32796926
Follicle-stimulating hormone (FSH) is closely related to the pathogenesis and progression of epithelial ovarian cancer (EOC). However, until now, knowledge relating to FSH-driven signalling pathways that lead to the growth...
5.
Long X, Song K, Hu H, Tian Q, Wang W, Dong Q, et al.
J Exp Clin Cancer Res
. 2019 Aug;
38(1):345.
PMID: 31391118
Background: Epithelial ovarian cancer (EOC) is the malignant tumor of the female reproductive system with the highest fatality rate. Tolerance of chemotherapeutic drugs like cisplatin (DDP) occurring in very early...
6.
Song K, Dai L, Long X, Cui X, Liu Y, Di W
Onco Targets Ther
. 2019 Jun;
12:4437-4449.
PMID: 31239712
ABC294640 is a non-lipid competitive inhibitor of SphK2. It exhibited anti-proliferative activities in many human malignancies, including ovarian cancer. However, its potential mechanism of action remains poorly understood. In this...
7.
Hu H, Duan Z, Long X, Hertzanu Y, Tong X, Xu X, et al.
PLoS One
. 2015 Feb;
10(2):e0117168.
PMID: 25689846
Aims: This retrospective study was carried out to compare the outcomes between elderly (≥70 years of age) and nonelderly patients (<70 years of age) with advanced hepatocellular carcinoma (HCC) who...
8.
Hu H, Duan Z, Long X, Hertzanu Y, Shi H, Liu S, et al.
PLoS One
. 2014 May;
9(5):e96620.
PMID: 24817002
Aims: The purpose of the present study was to compare the efficacies of transarterial chemoembolization (TACE) combined with sorafenib versus TACE monotherapy for treating patients with advanced hepatocellular carcinoma (HCC)....